Xeris Biopharma Holdings, Inc.
XERS
$5.99
-$0.09-1.40%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.64% | 21.23% | 54.50% | 1.45% | -18.40% |
| Total Receivables | 10.27% | -5.03% | 1.33% | 14.50% | 14.64% |
| Inventory | 8.10% | 1.80% | 0.27% | 27.69% | 9.37% |
| Prepaid Expenses | -1.52% | -14.80% | 87.93% | -1.18% | -19.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.73% | 7.27% | 20.71% | 13.51% | -2.49% |
|
|
|||||
| Total Current Assets | 4.73% | 7.27% | 20.71% | 13.51% | -2.49% |
| Net Property, Plant & Equipment | -0.28% | -0.56% | -1.73% | -0.37% | -1.49% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -3.08% | -2.99% | -2.90% | -2.82% | -2.74% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.88% | -1.82% | 5.04% | -0.71% | -5.71% |
| Total Assets | 2.21% | 3.60% | 10.61% | 6.10% | -2.35% |
|
|
|||||
| Total Accounts Payable | 272.79% | -52.87% | -31.02% | 48.96% | 177.38% |
| Total Accrued Expenses | 1.79% | -6.38% | 40.38% | 14.48% | -10.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.63% | 0.61% | 0.62% | -65.94% | -14.66% |
| Total Finance Division Other Current Liabilities | -3.28% | 9.12% | 2.10% | 7.83% | -1.54% |
| Total Other Current Liabilities | -3.28% | 9.12% | 2.10% | 7.83% | -1.54% |
| Total Current Liabilities | 8.23% | -5.70% | 22.10% | 0.10% | -5.35% |
|
|
|||||
| Total Current Liabilities | 8.23% | -5.70% | 22.10% | 0.10% | -5.35% |
| Long-Term Debt | 0.40% | 0.39% | 0.39% | 0.38% | 0.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.50% | -1.44% | -1.39% | -1.31% | -1.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -3.23% | 147.58% | -56.24% | 60.36% | 145.75% |
| Total Liabilities | 2.48% | -0.33% | 4.82% | 0.97% | -0.59% |
|
|
|||||
| Common Stock & APIC | -0.43% | 0.51% | 2.69% | 2.75% | 0.58% |
| Retained Earnings | 0.33% | 1.62% | 0.09% | -0.28% | -1.37% |
| Treasury Stock & Other | 4.00% | 0.00% | -4.17% | 4.00% | 0.00% |
| Total Common Equity | -4.95% | 1,689.90% | 95.54% | 45.05% | -18.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.95% | 1,689.90% | 95.54% | 45.05% | -18.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.95% | 1,689.90% | 95.54% | 45.05% | -18.62% |
|
|
|||||